Correlation Between Scpharmaceuticals and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Effector Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Effector Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Effector Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Effector is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Effector Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 0.39 times more return on investment than Effector Therapeutics. However, Scpharmaceuticals is 2.55 times less risky than Effector Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 846.00 in Scpharmaceuticals on September 12, 2024 and sell it today you would lose (485.00) from holding Scpharmaceuticals or give up 57.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 68.75% |
| Values | Daily Returns |
Scpharmaceuticals vs. Effector Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Scpharmaceuticals and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Effector Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |